CompletedNot Applicable

TTNS vs PTNS in a County Hospital System.

United States70 participantsStarted 2017-01-18

Plain-language summary

The goal of this clinical trial is to study whether transcutaneous tibial nerve stimulation (TTNS) is a feasible and satisfactory treatment for overactive bladder in Urogynecology patients who receive their care at a county hospital. Researchers will compare outcomes with TTNS to patients who undergo percutaneous tibial nerve stimulation (PTNS). The main questions it aims to answer are: * Is TTNS non-inferior to PTNS in terms of OAB symptom severity? * Are patients as satisfied with TTNS as they are with PTNS? * Are patients' symptoms improved with TTNS? Participants will: * either undergo PTNS or be taught how to do TTNS therapy at home * complete surveys about their bladder symptoms and satisfaction with treatment

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age between 18 - 90 years old * patient of the Urogynecology clinic at Harbor UCLA medical center * diagnosis of overactive bladder * patient elects non-pharmacologic treatment of overactive bladder * English or Spanish speaking * able to consent and participate in research Exclusion Criteria: * cognitive impairment or diagnosis of dementia * diagnosis of neurogenic bladder * prior midurethral sling procedure * use of an electronic pacemaker * current pregnancy * incarcerated persons

What they're measuring

ICIQ-OAB score

Timeframe: Baseline, 6 weeks, 12 weeks, 6 months post treatment initiation

Trial details

NCT IDNCT07353944

SponsorLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-04-30

View on ClinicalTrials.gov More Overactive Bladder trials